vs
Side-by-side financial comparison of MFA FINANCIAL, INC. (MFA) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $55.5M, roughly 1.4× MFA FINANCIAL, INC.). On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs 9.2%). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 7.7%).
MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
MFA vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.5M | $76.2M |
| Net Profit | — | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | 97.9% | 11.0% |
| Net Margin | — | 7.4% |
| Revenue YoY | 9.2% | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | $0.43 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.5M | $76.2M | ||
| Q3 25 | $56.8M | $71.9M | ||
| Q2 25 | $61.3M | $63.1M | ||
| Q1 25 | $57.5M | $59.1M | ||
| Q4 24 | $50.8M | $60.7M | ||
| Q3 24 | $50.6M | $58.0M | ||
| Q2 24 | $53.5M | $55.0M | ||
| Q1 24 | $47.8M | $50.6M |
| Q4 25 | — | $5.6M | ||
| Q3 25 | $48.1M | $3.5M | ||
| Q2 25 | $33.2M | $3.2M | ||
| Q1 25 | $41.2M | $2.6M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $48.2M | $3.9M | ||
| Q2 24 | $41.9M | $1.5M | ||
| Q1 24 | $23.2M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | 97.9% | 11.0% | ||
| Q3 25 | 84.5% | 7.8% | ||
| Q2 25 | 54.5% | 8.1% | ||
| Q1 25 | 70.0% | 6.5% | ||
| Q4 24 | 6.8% | 10.6% | ||
| Q3 24 | 98.2% | 9.7% | ||
| Q2 24 | 79.1% | 6.6% | ||
| Q1 24 | 50.7% | 4.4% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | 84.7% | 4.9% | ||
| Q2 25 | 54.2% | 5.0% | ||
| Q1 25 | 71.6% | 4.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | 95.2% | 6.7% | ||
| Q2 24 | 78.4% | 2.7% | ||
| Q1 24 | 48.5% | 3.2% |
| Q4 25 | $0.43 | $0.14 | ||
| Q3 25 | $0.35 | $0.09 | ||
| Q2 25 | $0.21 | $0.08 | ||
| Q1 25 | $0.31 | $0.06 | ||
| Q4 24 | $-0.01 | $0.10 | ||
| Q3 24 | $0.37 | $0.10 | ||
| Q2 24 | $0.32 | $0.04 | ||
| Q1 24 | $0.14 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $213.2M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.8B | $141.5M |
| Total Assets | $13.0B | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $213.2M | $13.5M | ||
| Q3 25 | $305.2M | $11.1M | ||
| Q2 25 | $275.7M | $20.0M | ||
| Q1 25 | $253.7M | $10.2M | ||
| Q4 24 | $338.9M | $17.5M | ||
| Q3 24 | $305.6M | $11.3M | ||
| Q2 24 | $289.4M | $8.8M | ||
| Q1 24 | $306.3M | $7.3M |
| Q4 25 | $1.8B | $141.5M | ||
| Q3 25 | $1.8B | $133.6M | ||
| Q2 25 | $1.8B | $139.7M | ||
| Q1 25 | $1.8B | $134.8M | ||
| Q4 24 | $1.8B | $131.4M | ||
| Q3 24 | $1.9B | $125.0M | ||
| Q2 24 | $1.9B | $119.4M | ||
| Q1 24 | $1.9B | $116.3M |
| Q4 25 | $13.0B | $199.2M | ||
| Q3 25 | $12.1B | $202.4M | ||
| Q2 25 | $11.7B | $184.6M | ||
| Q1 25 | $11.5B | $178.1M | ||
| Q4 24 | $11.4B | $177.1M | ||
| Q3 24 | $11.2B | $169.5M | ||
| Q2 24 | $11.1B | $163.9M | ||
| Q1 24 | $10.9B | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $76.2M | $18.4M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $76.2M | $18.4M | ||
| Q3 25 | $14.7M | $18.4M | ||
| Q2 25 | $38.5M | $12.3M | ||
| Q1 25 | $-14.6M | $2.9M | ||
| Q4 24 | $200.1M | $15.0M | ||
| Q3 24 | $-11.3M | $12.7M | ||
| Q2 24 | $46.5M | $10.2M | ||
| Q1 24 | $53.5M | $1.2M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | — | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | — | 11.5% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | 0.31× | 5.23× | ||
| Q2 25 | 1.16× | 3.88× | ||
| Q1 25 | -0.35× | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | -0.23× | 3.29× | ||
| Q2 24 | 1.11× | 6.94× | ||
| Q1 24 | 2.30× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
